Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · IEX Real-Time Price · USD
9.12
-0.08 (-0.87%)
At close: May 17, 2024, 4:00 PM
9.70
+0.58 (6.36%)
After-hours: May 17, 2024, 7:22 PM EDT
Avid Bioservices Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Avid Bioservices stock have an average target of 12.5, with a low estimate of 8.00 and a high estimate of 16. The average target predicts an increase of 37.06% from the current stock price of 9.12.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for CDMO stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | -12.28% | Apr 30, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Maintains $15 → $12 | Buy | Maintains | $15 → $12 | +31.58% | Mar 11, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $7 | Buy | Reiterates | $7 | -23.25% | Mar 7, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $15 → $7 | Buy | Maintains | $15 → $7 | -23.25% | Dec 8, 2023 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $22 → $16 | Strong Buy | Maintains | $22 → $16 | +75.44% | Dec 8, 2023 |
Financial Forecast
Revenue This Year
141.43M
from 149.27M
Decreased by -5.25%
Revenue Next Year
168.85M
from 141.43M
Increased by 19.39%
EPS This Year
-0.27
EPS Next Year
-0.06
from -0.27
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 147.1M | 183.8M | 246.8M | 265.9M | 555.2M | 721.8M |
| Avg | 141.4M | 168.9M | 217.4M | 258.3M | 539.3M | 701.1M |
| Low | 134.3M | 153.9M | 197.0M | 248.1M | 518.2M | 673.6M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.4% | 29.9% | 46.1% | 22.3% | 115.0% | 33.8% |
| Avg | -5.2% | 19.4% | 28.7% | 18.8% | 108.8% | 30.0% |
| Low | -10.1% | 8.8% | 16.7% | 14.1% | 100.7% | 24.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.25 | 0.03 | 0.37 |
| Avg | -0.27 | -0.06 | 0.18 |
| Low | -0.29 | -0.18 | 0.01 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.